As the global burden of metabolic dysfunction–associated steatotic liver disease in children and adolescents continues to rise, endoscopic, surgical and pharmacologic therapies may be effective options for some of these children, who are at increased risk for early mortality.
Surgical Options
“Metabolic bariatric surgeries are evidence-based, effective and safe treatments that should be offered to eligible adolescents with severe obesity and metabolic diseases, including MASLD,”